investigational marketing authorisation

MHRA Launches Consultation on Draft Rare Disease Therapies Regulatory Framework

A public consultation has been launched on a draft Rare Disease Therapies Regulatory Framework, with comments accepted until 30 July 2026. The proposed framework aims to address challenges…